PMV Pharmaceuticals, Inc.
PMVP
Cena:
$ 1.26
-0.02 (-1.56%)
Valuace
70
Růst
23
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
PMV PHARMACEUTICALS ANNOUNCES UPDATED REZATAPOPT MONOTHERAPY INTERIM DATA FROM ONGOING PYNNACLE PHASE 2 TRIAL ACROSS MULTIPLE SOLID TUMORS WITH A TP53 Y220C MUTATION
24-10-2025
PRINCETON, N.J., OCT. 24, 2025 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (“PMV PHARMA” OR T...
Více zde
PMV PHARMACEUTICALS TO PRESENT REZATAPOPT PIVOTAL PHASE 2 INITIAL ANALYSIS AND NATURAL HISTORY STUDY RESULTS AT THE 2025 AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS
13-10-2025
PRINCETON, N.J., OCT. 13, 2025 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (“PMV PHARMA” OR TH...
Více zde
PMV PHARMACEUTICALS ANNOUNCES PROMISING REZATAPOPT MONOTHERAPY INTERIM DATA FROM PYNNACLE PHASE 2 TRIAL ACROSS MULTIPLE SOLID TUMORS WITH A TP53 Y220C MUTATION
10-09-2025
PRINCETON, N.J., SEPT. 10, 2025 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (“PMV PHARMA” OR ...
Více zde
PMV PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
07-08-2025
PRINCETON, N.J., AUG. 07, 2025 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (“PMV PHARMA” OR TH...
Více zde
PMV PHARMACEUTICALS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES
23-05-2025
PRINCETON, N.J., MAY 23, 2025 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (“PMV PHARMA”; NASDA...
Více zde
PMV PHARMACEUTICALS REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
03-03-2025
ENROLLMENT ON TRACK IN PHASE 2 PIVOTAL PORTION OF PYNNACLE CLINICAL TRIAL EVALUATING REZATAPOPT AS M...
Více zde
PMV PHARMACEUTICALS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES
11-02-2025
PRINCETON, N.J., FEB. 11, 2025 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRECI...
Více zde
FOUNDATION MEDICINE AND PMV PHARMA ANNOUNCE COLLABORATION TO DEVELOP COMPANION DIAGNOSTIC FOR REZATAPOPT, A FIRST-IN-CLASS, INVESTIGATIONAL, SELECTIVE P53 Y220C REACTIVATOR
29-05-2024
BOSTON AND PRINCETON, N.J., MAY 29, 2024 (GLOBE NEWSWIRE) -- FOUNDATION MEDICINE, INC. AND PMV PHARM...
Více zde
PMV PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
09-05-2024
PRINCETON, N.J., MAY 09, 2024 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRECIS...
Více zde
PMV PHARMACEUTICALS ANNOUNCES FIRST PATIENT DOSED IN GLOBAL TUMOR-AGNOSTIC PHASE 2 PYNNACLE TRIAL FOR REZATAPOPT IN TP53 Y220C-POSITIVE SOLID TUMORS
27-03-2024
PRINCETON, N.J., MARCH 27, 2024 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS PYNNACLE PHASE I DATA OF REZATAPOPT IN ADVANCED OVARIAN CANCER FEATURED IN LATE-BREAKING ORAL PRESENTATION AT 2024 SGO ANNUAL MEETING ON WOMEN'S CANCER
18-03-2024
PRINCETON, N.J., MARCH 18, 2024 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS REPORTS FULL YEAR 2023 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
29-02-2024
PRINCETON, N.J., FEB. 29, 2024 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRECI...
Více zde
PMV PHARMACEUTICALS ANNOUNCES PRIORITIZATION OF PC14586 CLINICAL DEVELOPMENT AND EXTENDED CASH RUNWAY
18-01-2024
PRINCETON, N.J., JAN. 18, 2024 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS STRENGTHENS LEADERSHIP WITH KEY APPOINTMENTS AS COMPANY ADVANCES INTO LATE-STAGE DEVELOPMENT
05-01-2024
PRINCETON, N.J., JAN. 05, 2024 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
09-11-2023
PRINCETON, N.J., NOV. 09, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS UPDATED PC14586 PHASE 1 DATA DEMONSTRATED ANTI-TUMOR ACTIVITY ACROSS MULTIPLE SOLID TUMOR TYPES WITH A TP53 Y220C MUTATION
12-10-2023
PRINCETON, N.J., OCT. 12, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS TO PRESENT UPDATED PHASE 1 DATA ON PC14586 AT THE 2023 AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS AND HOST A KOL WEBINAR
11-10-2023
PRINCETON, N.J., OCT. 11, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS TO PRESENT UPDATED PHASE 1 DATA ON PC14586 AT THE 2023 AACR-NCI-EORTC INTERNATIONAL CONFERENCE ON MOLECULAR TARGETS AND CANCER THERAPEUTICS
20-09-2023
PRINCETON, N.J., SEPT. 20, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRE...
Více zde
PMV PHARMACEUTICALS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
09-08-2023
PRINCETON, N.J., AUG. 09, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS TO PARTICIPATE IN THE GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE
06-06-2023
PRINCETON, N.J., JUNE 06, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRECI...
Více zde
PMV PHARMACEUTICALS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
10-05-2023
PRINCETON, N.J., MAY 10, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRECIS...
Více zde
PMV PHARMACEUTICALS REPORTS FULL YEAR 2022 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
01-03-2023
PRINCETON, N.J., MARCH 01, 2023 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PREC...
Více zde
PMV PHARMACEUTICALS TO PARTICIPATE IN THE 5TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE
22-11-2022
CRANBURY, N.J., NOV. 22, 2022 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP; “PMV PH...
Více zde
PMV PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
08-11-2022
CRANBURY, N.J., NOV. 08, 2022 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRECI...
Více zde
PMV PHARMACEUTICALS APPOINTS INDUSTRY VETERAN DR. CAROL GALLAGHER TO BOARD OF DIRECTORS
04-11-2022
CRANBURY, N.J., NOV. 04, 2022 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP), A PRECI...
Více zde
PMV PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
09-08-2022
CRANBURY, N.J., AUG. 09, 2022 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (“PMV PHARMA” NASDA...
Více zde
PMV PHARMACEUTICALS ANNOUNCES A CLINICAL TRIAL COLLABORATION WITH MERCK TO EVALUATE PC14586 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) IN PATIENTS WITH ADVANCED SOLID TUMORS
18-07-2022
COMBINATION TRIAL TO BE INITIATED IN Q4 2022 COMBINATION TRIAL TO BE INITIATED IN Q4 2022...
Více zde
PMV PHARMACEUTICALS TO PARTICIPATE IN THE GOLDMAN SACHS GLOBAL HEALTHCARE CONFERENCE
08-06-2022
CRANBURY, N.J., JUNE 08, 2022 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP; “PMV PH...
Více zde
PMV PHARMACEUTICALS INITIAL PC14586 PHASE 1 DATA PRESENTED AT ASCO DEMONSTRATED ANTI-TUMOR ACTIVITY ACROSS MULTIPLE SOLID TUMOR TYPES WITH A P53 Y220C MUTATION
07-06-2022
CRANBURY, N.J., JUNE 07, 2022 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP; “PMV P...
Více zde
PMV PHARMACEUTICALS ANNOUNCES INITIAL PC14586 PHASE 1 CLINICAL DATA TO BE PRESENTED AT THE 2022 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING
26-05-2022
CRANBURY, N.J., MAY 26, 2022 (GLOBE NEWSWIRE) -- PMV PHARMACEUTICALS, INC. (NASDAQ: PMVP; “PMV PH...
Více zde
| Datum | Typ | Otevřít EDGAR | Stáhnout dokument |
|---|---|---|---|
| 2025-11-12 00:00:00 | 8-K |  | Stáhnout |
| 2025-11-12 00:00:00 | 10-Q | | Stáhnout |
| 2025-09-10 01:00:00 | 8-K | | Stáhnout |
| 2025-09-10 00:00:00 | 8-K | | Stáhnout |
| 2025-08-07 01:00:00 | 8-K | | Stáhnout |
| 2025-08-07 01:00:00 | 10-Q | | Stáhnout |
| 2025-08-07 00:00:00 | 8-K | | Stáhnout |
| 2025-08-07 00:00:00 | 10-Q | | Stáhnout |
| 2025-06-09 01:00:00 | 8-K | | Stáhnout |
| 2025-06-09 00:00:00 | 8-K | | Stáhnout |
| 2025-05-09 01:00:00 | 8-K | | Stáhnout |
| 2025-05-09 01:00:00 | 10-Q | | Stáhnout |
| 2025-05-09 00:00:00 | 8-K | | Stáhnout |
| 2025-05-09 00:00:00 | 10-Q | | Stáhnout |
| 2025-03-03 00:00:00 | 8-K | | Stáhnout |
| 2025-03-03 00:00:00 | 10-K | | Stáhnout |
| 2025-03-02 23:00:00 | 8-K | | Stáhnout |
| 2025-03-02 23:00:00 | 10-K | | Stáhnout |
| 2024-11-07 00:00:00 | 8-K | | Stáhnout |
| 2024-11-07 00:00:00 | 10-Q | | Stáhnout |
| 2024-11-06 23:00:00 | 8-K | | Stáhnout |
| 2024-11-06 23:00:00 | 10-Q | | Stáhnout |
| 2024-08-08 01:00:00 | 8-K | | Stáhnout |
| 2024-08-08 01:00:00 | 10-Q | | Stáhnout |
| 2024-08-08 00:00:00 | 8-K | | Stáhnout |
| 2024-08-08 00:00:00 | 10-Q | | Stáhnout |
| 2024-06-07 01:00:00 | 8-K | | Stáhnout |
| 2024-06-07 00:00:00 | 8-K | | Stáhnout |
| 2024-05-09 01:00:00 | 8-K | | Stáhnout |
| 2024-05-09 01:00:00 | 10-Q | | Stáhnout |
| 2024-05-09 00:00:00 | 8-K | | Stáhnout |
| 2024-05-09 00:00:00 | 10-Q | | Stáhnout |
| 2024-02-29 00:00:00 | 8-K | | Stáhnout |
| 2024-02-29 00:00:00 | 10-K | | Stáhnout |
| 2024-02-28 23:00:00 | 8-K | | Stáhnout |
| 2024-02-28 23:00:00 | 10-K | | Stáhnout |
| 2024-01-18 00:00:00 | 8-K | | Stáhnout |
| 2024-01-17 23:00:00 | 8-K | | Stáhnout |
| 2024-01-05 00:00:00 | 8-K | | Stáhnout |
| 2024-01-04 23:00:00 | 8-K | | Stáhnout |
| 2023-11-09 00:00:00 | 8-K | | Stáhnout |
| 2023-11-09 00:00:00 | 10-Q | | Stáhnout |
| 2023-11-08 23:00:00 | 8-K | | Stáhnout |
| 2023-11-08 23:00:00 | 10-Q | | Stáhnout |
| 2023-10-12 01:00:00 | 8-K | | Stáhnout |
| 2023-10-12 00:00:00 | 8-K | | Stáhnout |
| 2023-10-11 01:00:00 | 8-K | | Stáhnout |
| 2023-10-11 00:00:00 | 8-K | | Stáhnout |
| 2023-08-09 01:00:00 | 8-K | | Stáhnout |
| 2023-08-09 01:00:00 | 10-Q | | Stáhnout |
| 2023-08-09 00:00:00 | 8-K | | Stáhnout |
| 2023-08-09 00:00:00 | 10-Q | | Stáhnout |
| 2023-06-09 01:00:00 | 8-K | | Stáhnout |
| 2023-06-09 00:00:00 | 8-K | | Stáhnout |
| 2023-05-10 01:00:00 | 8-K | | Stáhnout |
| 2023-05-10 01:00:00 | 10-Q | | Stáhnout |
| 2023-05-10 00:00:00 | 8-K | | Stáhnout |
| 2023-05-10 00:00:00 | 10-Q | | Stáhnout |
| 2023-04-28 01:00:00 | 8-K | | Stáhnout |
| 2023-04-28 00:00:00 | 8-K | | Stáhnout |
| 2023-03-01 00:00:00 | 8-K | | Stáhnout |
| 2023-03-01 00:00:00 | 10-K | | Stáhnout |
| 2023-02-28 23:00:00 | 8-K | | Stáhnout |
| 2023-02-28 23:00:00 | 10-K | | Stáhnout |
| 2022-11-08 00:00:00 | 8-K | | Stáhnout |
| 2022-11-08 00:00:00 | 10-Q | | Stáhnout |
| 2022-11-07 23:00:00 | 8-K | | Stáhnout |
| 2022-11-07 23:00:00 | 10-Q | | Stáhnout |
| 2022-11-04 00:00:00 | 8-K | | Stáhnout |
| 2022-11-03 23:00:00 | 8-K | | Stáhnout |
| 2022-08-09 01:00:00 | 8-K | | Stáhnout |
| 2022-08-09 01:00:00 | 10-Q | | Stáhnout |
| 2022-08-09 00:00:00 | 8-K | | Stáhnout |
| 2022-08-09 00:00:00 | 10-Q | | Stáhnout |
| 2022-06-08 01:00:00 | 8-K | | Stáhnout |
| 2022-06-08 00:00:00 | 8-K | | Stáhnout |
| 2022-06-06 01:00:00 | 8-K | | Stáhnout |
| 2022-06-06 00:00:00 | 8-K | | Stáhnout |
| 2022-05-26 01:00:00 | 8-K | | Stáhnout |
| 2022-05-26 00:00:00 | 8-K | | Stáhnout |
| 2022-05-10 01:00:00 | 8-K | | Stáhnout |
| 2022-05-10 01:00:00 | 10-Q | | Stáhnout |
| 2022-05-10 00:00:00 | 8-K | | Stáhnout |
| 2022-05-10 00:00:00 | 10-Q | | Stáhnout |
| 2022-03-01 00:00:00 | 8-K | | Stáhnout |
| 2022-03-01 00:00:00 | 10-K | | Stáhnout |
| 2022-02-28 23:00:00 | 8-K | | Stáhnout |
| 2022-02-28 23:00:00 | 10-K | | Stáhnout |
| 2022-01-06 00:00:00 | 8-K | | Stáhnout |
| 2022-01-05 23:00:00 | 8-K | | Stáhnout |
| 2021-11-12 00:00:00 | 8-K | | Stáhnout |
| 2021-11-12 00:00:00 | 10-Q | | Stáhnout |
| 2021-11-11 23:00:00 | 8-K | | Stáhnout |
| 2021-11-11 23:00:00 | 10-Q | | Stáhnout |
| 2021-10-05 01:00:00 | 8-K | | Stáhnout |
| 2021-10-05 00:00:00 | 8-K | | Stáhnout |
| 2021-08-13 01:00:00 | 8-K | | Stáhnout |
| 2021-08-13 01:00:00 | 10-Q | | Stáhnout |
| 2021-08-13 00:00:00 | 8-K | | Stáhnout |
| 2021-08-13 00:00:00 | 10-Q | | Stáhnout |
| 2021-06-07 01:00:00 | 8-K | | Stáhnout |
| 2021-06-07 00:00:00 | 8-K | | Stáhnout |
| 2021-05-14 01:00:00 | 8-K | | Stáhnout |
| 2021-05-14 01:00:00 | 10-Q | | Stáhnout |
| 2021-05-14 00:00:00 | 8-K | | Stáhnout |
| 2021-05-14 00:00:00 | 10-Q | | Stáhnout |
| 2021-04-06 01:00:00 | 8-K | | Stáhnout |
| 2021-04-06 00:00:00 | 8-K | | Stáhnout |
| 2021-03-03 00:00:00 | 8-K | | Stáhnout |
| 2021-03-03 00:00:00 | 10-K | | Stáhnout |
| 2021-03-02 23:00:00 | 8-K | | Stáhnout |
| 2021-03-02 23:00:00 | 10-K | | Stáhnout |
| 2020-11-13 00:00:00 | 8-K | | Stáhnout |
| 2020-11-13 00:00:00 | 10-Q | | Stáhnout |
| 2020-11-12 23:00:00 | 8-K | | Stáhnout |
| 2020-11-12 23:00:00 | 10-Q | | Stáhnout |
| 2020-09-29 01:00:00 | 8-K | | Stáhnout |
| 2020-09-29 00:00:00 | 8-K | | Stáhnout |
